Intensity Therapeutics INTS
NASDAQ INTS
$3.25 +0.06 (+1.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

Intensity Therapeutics (INTS) Cash from Investing Activities (2023 - 2024)

Updated

Intensity Therapeutics' Cash from Investing Activities was $6.35 million in FY2024, compared with -$6.02 million in FY2023.

Analysis

Intensity Therapeutics (INTS) Cash from Investing Activities (2023 - 2024) Analysis & Trends

  • Per Business Quant data, Cash from Investing Activities in earlier years was -$6.02 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -1.20 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.11 Bn
10 Intensity Therapeutics 9.57 Mn -29.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 3.10 Mn
Jun 30, 2024 -6,000.00
Mar 31, 2024 3.26 Mn
Dec 31, 2023 2.82 Mn
Sep 30, 2023 -8.84 Mn
API Access

Intensity Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=INTS&period=max&api_key=YOUR_API_KEY